Fast Facts and Concepts #484: Opioid Diversion Risk and Management in Palliative Care

U.S. Department of Health and Human Services. Drug Diversion in the Medicaid Program: State Strategies for Reducing Prescription Drug Diversion in Medicaid. Baltimore: Centers for Medicare & Medicaid Services; 2012. Available from: https://www.cms.gov/Medicare-Medicaid-Coordination/Fraud-Prevention/MedicaidIntegrityProgram/downloads/drugdiversion.pdf

Markotic F , Jurisic D , Curkovic M , et al. Sharing of prescription analgesics amongst patients in family practice: Frequency and associated factors. Eur J Pain, 2018; 22(4):716–727.

Beyene KA , Sheridan J , Aspden T . Prescription medication sharing: A systematic review of the literature. Am J Public Health, 2014; 104(4):e15-26–e26.

Colliver JD , Gfroerer JC . Motive for nonmedical use of prescription pain relievers in the national survey on drug use and health. J Pain, 2008; 9:487–489.

Harris S , Nikulina V , Gelpí-Acosta C , et al. Prescription drug diversion: Predictors of illicit acquisition and redistribution in three U.S. metropolitan areas. AIMS Public Health, 2015; 2(4):762–783.

Ware OD , Cagle JG , McPherson ML , et al. Confirmed medication diversion in hospice care: Qualitative findings from a national sample of agencies. J Pain Symptom Manage, 2021; 61(4):789–796.

Centers for Disease Control and Prevention. Vital signs: Overdoses of prescription opioid pain relievers – United States, 1999-2008. Morbidity and Mortality Weekly Report. Published November 4, 2011. Accessed December 2, 2023. Available at: https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6043a4.htm

Hall AJ , Logan JE , Toblin RL , et al. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA. 2008; 300(22):2613–2620.

Dale R , Edwards J , Ballantyne J . Opioid risk assessment in palliative medicine. J Community Support Oncol, 2016; 14(3):94–100.

Lau J , Mazzotta P , Whelan C , et al. Opioid safety recommendations in adult palliative medicine: A North American Delphi expert consensus. BMJ Support Palliat Care, 2022; 12(1):81–90.

Jones T , Moore TM , Meske DS , Passik SD . Preliminary validation of the Diversion Risk Scale (DRS): Using environmental and individual factors to predict opioid-related diversion events. J Opioid Manag, 2023; 19(1):35–42.

Dowell D , Ragan KR , Jones CM , et al. CDC clinical practice guideline for prescribing opioids for pain—United States, 2022. MMWR Recomm Rep, 2022; 71(3):1–95.

Arthur JA , Haider A , Edwards T , et al. Aberrant opioid use and urine drug testing in outpatient palliative care. J Palliat Med, 2016; 19(7):778–782.

Schäfer WLA , Johnson JK , Wafford QE , et al. Primary prevention of prescription opioid diversion: A systematic review of medication disposal interventions. Am J Drug Alcohol Abuse, 2021; 47(5):548–558.

Ware O , McPherson ML , Barclay JS , et al. Recommendations for preventing medication diversion and misuse in hospice care: A modified Delphi study. J Pain Symptom Manage, 2021; 62(6):1175–1187.

Cosgrove JC . Preventing Drug Diversion: Disposal of controlled substances in home hospice settings. Washington DC: United States Government Accountability Office; 2020. Available from: https://www.gao.gov/assets/gao-20-378.pdf